ALXO ALX ONCOLOGY HOLDINGS INC Other Situations 8-K Filing 2023 - Study Protocol and Interim Analysis Disclosure ALX Oncology Holdings Inc. disclosed additional information on the study protocol and interim analysis of its ASPEN-06 study.Get access to all SEC 8-K filings of the ALX ONCOLOGY HOLDINGS INC